Statistics for Pharma Mar SA (id:4703 PHM)

Valuation metrics

Market cap

1.32B

Enterprise value

1.24B

Trailing P/E (ttm)

1.89K

Forward P/E

20.53

PEG ratio

20.53

Price/Sales (ttm)

7.88

Price/Book (mrq)

7.29

Enterprise Value/Revenue

7.41

Enterprise Value/EBITDA

-2,594.66

Overview

Shares outstanding

17.38M

Float

13.63M

Shares short

% Held by insiders

0.21%

% Held by institutions

0.07%

Average volume (10 days)

77.56K

Average volume (90 days)

Price summary

52-Week low

26.16

52-Week high

83.70

52-Week change

48.36%

Beta

0.04

50-Day moving average

57.99

200-Day moving average

40.08

Dividends and splits

Forward annual dividend rate

2.60

Forward annual dividend yield

0.03

Trailing annual dividend rate

0.65%

Trailing annual dividend yield

0.01

5-Year annual dividend yield

Payout ratio

15.81

Dividend date

Ex-dividend date

June 12th, 2024

Last split factor

2:1

Last split date

July 22th, 2020

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.37%

Operating margin

12.00%

Operational effectiveness

Return on assets

-0.65%

Return on equity

0.32%

Income statement

Revenue (ttm)

9.52

Revenue per share (ttm)

9.52

Quarterly revenue growth (yoy)

1.57

Gross profit (ttm)

148.54M

EBITDA

4.08M

Net income to common (ttm)

622.00K

Diluted EPS (ttm)

0.04

Quarterly earnings growth (yoy)

156.70%

Balance sheet

Total cash (mrq)

144.39M

Total cash per share (mrq)

8.23

Total debt (mrq)

53.48M

Total Debt/Equity (mrq)

29.36

Current ratio (mrq)

266.10%

Book value per share (mrq)

10.39

Cash flow

Cash flow statement

1.65M

Levered free cash flow (LFCF)

-17,049,376.00